1 active not recruiting, 1 completed. 2 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Active not recruiting 1, Completed 1 |
| Phase 1 | 1 | Completed 1 |
Follow RhoVac APS: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of RV001V in Biochemical Failure Following Curatively Intended Therapy For Localized Prostate Cancer RV001V, Placebo - Prostate Cancer Recurrent | Phase 2 | Active not recruiting | RhoVac APS | 180 | 2019-11-19 | 2021-09-28 |
| RV001V, a RhoC Anticancer Vaccine, Against Metastasis From Solid Tumours RV001V - Prostate Cancer | Phase 1 / Phase 2 | Completed | RhoVac APS | 22 | 2017-03-30 | 2020-06-09 |
Denmark (2) · Belgium (1) · Finland (1) · Germany (1) · Sweden (1) · United Kingdom (1) · United States (1)
Jesper Sonne, MD, PhD (1) · Klaus Brasso, MD (1)